NCT00634010 Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain Status TERMINATED Phase PHASE3
NCT00629200 Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00628732 A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors Status COMPLETED Phase PHASE2
NCT00618124 A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together Status COMPLETED Phase PHASE1
NCT00615446 A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00613847 Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab Status COMPLETED Phase PHASE1
NCT00611689 Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00606814 Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00606437 Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants Status COMPLETED Phase PHASE1
NCT00600275 A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00591682 MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors Status SUSPENDED Phase PHASE1
NCT00586560 Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010) Status COMPLETED Phase PHASE1
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00585221 Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients Status TERMINATED Phase PHASE2
NCT00583063 Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers Status COMPLETED Phase EARLY_PHASE1